Arlene Weintraub is a science journalist and author with 20 years of experience writing about healthcare, pharmaceuticals and biotechnology.
The White House has endorsed a seven-year limit to data exclusivity. One big winner: Teva Pharmaceuticals
A huge jackpot awaits the company that devises an effective fix for obesity
Like hundreds of other executives whose companies are trying to develop blockbuster weight-loss drugs, Amylin Pharmaceutical...
Amgen is likely to receive FDA approval for denosumab, its newbiologic bone-loss drug, but it may be a hard sell against cheaper generics
The drug industry is spending billions on TV ads, but they may be scaring consumers away
Now that it has acquired the biotech superstar, success will depend on keeping some distance